Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott R Evans

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
Statistics in Biopharmaceutical Research|October 12, 2020
Interim Monitoring for Futility in Clinical Trials with Two Co-primary Endpoints Using PredictionKoko Asakura, Scott R Evans, Toshimitsu Hamasaki
NEJM Evidence|February 6, 2024
The Data and Safety Monitoring Board: The Toughest Job in Clinical TrialsScott R Evans, Lijuan Zeng, Weixiao Dai
Biometrical Journal. Biometrische Zeitschrift|October 21, 2016
Interim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpointsKoko Asakura, Toshimitsu Hamasaki, Scott R Evans
Therapeutic Innovation & Regulatory Science|December 10, 2024
Data Monitoring Committee Reports: Telling the Data's StoryLijuan Zeng, Toshimitsu Hamasaki, Scott R Evans
Journal of Biopharmaceutical Statistics|October 31, 2017
Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A reviewToshimitsu Hamasaki, Scott R Evans, Koko Asakura
Statistics in Medicine|February 12, 2026
Patient-Centric Pragmatic Clinical Trials: Opening the DOORScott R Evans, Qihang Wu, Toshimitsu Hamasaki
Therapeutic Innovation & Regulatory Science|December 17, 2024
Inside the Mind of the DMC: A Review of Principles and Issues with Case StudiesLizhao Ge, Toshimitsu Hamasaki, Scott R Evans
BMJ (Clinical Research Ed.)|February 24, 2018
Studying new antibiotics for multidrug resistant infections: are today's patients paying for unproved future benefits?John H Powers, Scott R Evans, Aaron S Kesselheim
Lifetime Data Analysis|April 14, 2019
Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomesTomoyuki Sugimoto, Toshimitsu Hamasaki, Scott R Evans, et al.
Biostatistics (Oxford, England)|June 18, 2016
Corrigendum: A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpoints (10.1093/biostatistics/kxs057)Tomoyuki Sugimoto, Takashi Sozu, Toshimitsu Hamasaki, et al.
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
Statistics in Biopharmaceutical Research|October 12, 2020
Interim Monitoring for Futility in Clinical Trials with Two Co-primary Endpoints Using PredictionKoko Asakura, Scott R Evans, Toshimitsu Hamasaki
NEJM Evidence|February 6, 2024
The Data and Safety Monitoring Board: The Toughest Job in Clinical TrialsScott R Evans, Lijuan Zeng, Weixiao Dai
Biometrical Journal. Biometrische Zeitschrift|October 21, 2016
Interim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpointsKoko Asakura, Toshimitsu Hamasaki, Scott R Evans
Therapeutic Innovation & Regulatory Science|December 10, 2024
Data Monitoring Committee Reports: Telling the Data's StoryLijuan Zeng, Toshimitsu Hamasaki, Scott R Evans
Journal of Biopharmaceutical Statistics|October 31, 2017
Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A reviewToshimitsu Hamasaki, Scott R Evans, Koko Asakura
Statistics in Medicine|February 12, 2026
Patient-Centric Pragmatic Clinical Trials: Opening the DOORScott R Evans, Qihang Wu, Toshimitsu Hamasaki
Therapeutic Innovation & Regulatory Science|December 17, 2024
Inside the Mind of the DMC: A Review of Principles and Issues with Case StudiesLizhao Ge, Toshimitsu Hamasaki, Scott R Evans
BMJ (Clinical Research Ed.)|February 24, 2018
Studying new antibiotics for multidrug resistant infections: are today's patients paying for unproved future benefits?John H Powers, Scott R Evans, Aaron S Kesselheim
Lifetime Data Analysis|April 14, 2019
Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomesTomoyuki Sugimoto, Toshimitsu Hamasaki, Scott R Evans, et al.
Biostatistics (Oxford, England)|June 18, 2016
Corrigendum: A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpoints (10.1093/biostatistics/kxs057)Tomoyuki Sugimoto, Takashi Sozu, Toshimitsu Hamasaki, et al.
Pageof 14